Bio-Rad Labs Inc. A buy UBS Group AG
Start price
03.05.25
/
50%
€205.90
Target price
03.05.26
€274.38
Performance (%)
31.23%
Price
11:03
€265.20
Summary
This prediction is currently active. With a performance of 31.23% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 03.05.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Rad Labs Inc. A | 0.072% | 0.072% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at UBS Group AG from $355.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€248.20
08.05.24
08.05.24
€357.93
08.05.25
08.05.25
-12.97%
09.05.25
09.05.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€389.51
16.02.25
16.02.25
-15.75%
17.02.25
17.02.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€285.60
07.12.23
07.12.23
€365.97
07.12.24
07.12.24
8.65%
08.12.24
08.12.24